KDD 2020: Geneia CATO discusses COVID-19 data science | Geneia

KDD 2020: Geneia CATO discusses COVID-19 data science


August 25, 2020


KDD 2020: Geneia CATO discusses COVID-19 data science

Harrisburg, PAGeneia, a healthcare analytic solutions and services company that is simplifying the transition to value-based care, announces its chief analytics and technology officer, Fred, Rahmanian, will join a prestigious collection of speakers at KDD 2020. Moderated by Bharat Rao, PhD, leader, Healthcare and Life Sciences Data Analytics at KPMG, Rahmanian’s panel, Emerging Data Science Challenges in the era of COVID-19, today at 7 pm Eastern, features:

  • Tom Frieden, MD, MPH, former CDC Director, President and CEO, Resolve to Save Lives
  • Professor Tanya Berger-Wolf, Director, Translational Data Institute, Ohio State University
  • Kash Patel, MS, Chief Digital Health Officer, Penn Medicine
  • Professor Geoff Webb, Research Director, Monash University Data Futures Institute
“Without a doubt, data science is accelerating our recovery from the COVID-19 pandemic,” said Rahmanian. “One of many examples is the COVID-19 severe impacts model created by the Geneia Data Intelligence Lab. The model predicts which patients are at high risk for developing severe adverse health outcomes if they contract COVID-19.”

KDD 2020 is the 26th Association for Computing Machinery SIGKDD Conference on Knowledge Discovery and Data Mining, the world’s oldest and largest community for data mining, data science and analytics and the conference at which many of the new data science advancements are published. For more information about KDD 2020, click here.

ABOUT GENEIA
Geneia LLC is a healthcare analytics and services company. We work to improve collaboration between healthcare providers, health plans and employers to better support personalized, patient-centered care. Through advanced technology, education and training, insights and clinical services, we help clients better identify and actively manage high-risk populations, improve quality measurement and outcomes, and strengthen revenue. Rooted in deep clinical experience and leading-edge data science, our client-centric, phased approach to population health simplifies the transition to risk and value-based care. Our offices are located in Harrisburg, PA and Manchester, NH. To learn more, visit Geneia.com (https://www.geneia.com) or connect with us on Facebook, Twitter and LinkedIn.